Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saishravan Shyamsundar

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|May 7, 2026
Nuclear diplomacy continues to be structurally flawed because it excludes doctorsSaishravan Shyamsundar, Ira Helfand
BMJ (Clinical Research Ed.)|March 25, 2026
Communicating science in a misinformed era: innovative strategies for global physiciansSaishravan Shyamsundar, Eric A Friedman, Lawrence O Gostin
JMIR Medical Education|July 18, 2022
Opioid Use Disorder Education for Students and the Future of Opioid Overdose TreatmentNeha Balapal, Amala Ankem, Saishravan Shyamsundar, et al.
JMIR Human Factors|January 27, 2023
Primary Perspectives in Meme Utilization as a Digital Driver for Medical Community Engagement and Education Mobilization: Pre-Post StudyDarrel Wang, Neha Balapal, Amala Ankem, et al.
Scientific Reports|January 11, 2025
No evidence for active viral infection in unicentric and idiopathic multicentric Castleman disease by Viral-Track analysisIra Miller, Melanie D Mumau, Saishravan Shyamsundar, et al.
Digital Health|October 13, 2022
Analyzing opioid-use disorder websites in the United States: An optimized website usability studyShuhan He, Saishravan Shyamsundar, Paul Chong, et al.
The New England Journal of Medicine|February 5, 2025
Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman's DiseaseMelanie D Mumau, Michael V Gonzalez, Chunyu Ma, et al.
British Journal of Haematology|January 3, 2024
Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman diseaseAyelet I Rubenstein, Sheila K Pierson, Saishravan Shyamsundar, et al.
Blood Neoplasia|July 24, 2024
Castleman disease patients report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccinationSaishravan Shyamsundar, Sheila K Pierson, Caoilfhionn M Connolly, et al.
European Journal of Haematology|August 30, 2024
Idiopathic multicentric Castleman disease with marrow fibrosis and extramedullary hematopoiesisMarley Blommers, Sorin Selegean, Richard K Wood, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|May 7, 2026
Nuclear diplomacy continues to be structurally flawed because it excludes doctorsSaishravan Shyamsundar, Ira Helfand
BMJ (Clinical Research Ed.)|March 25, 2026
Communicating science in a misinformed era: innovative strategies for global physiciansSaishravan Shyamsundar, Eric A Friedman, Lawrence O Gostin
JMIR Medical Education|July 18, 2022
Opioid Use Disorder Education for Students and the Future of Opioid Overdose TreatmentNeha Balapal, Amala Ankem, Saishravan Shyamsundar, et al.
JMIR Human Factors|January 27, 2023
Primary Perspectives in Meme Utilization as a Digital Driver for Medical Community Engagement and Education Mobilization: Pre-Post StudyDarrel Wang, Neha Balapal, Amala Ankem, et al.
Scientific Reports|January 11, 2025
No evidence for active viral infection in unicentric and idiopathic multicentric Castleman disease by Viral-Track analysisIra Miller, Melanie D Mumau, Saishravan Shyamsundar, et al.
Digital Health|October 13, 2022
Analyzing opioid-use disorder websites in the United States: An optimized website usability studyShuhan He, Saishravan Shyamsundar, Paul Chong, et al.
The New England Journal of Medicine|February 5, 2025
Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman's DiseaseMelanie D Mumau, Michael V Gonzalez, Chunyu Ma, et al.
British Journal of Haematology|January 3, 2024
Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman diseaseAyelet I Rubenstein, Sheila K Pierson, Saishravan Shyamsundar, et al.
Blood Neoplasia|July 24, 2024
Castleman disease patients report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccinationSaishravan Shyamsundar, Sheila K Pierson, Caoilfhionn M Connolly, et al.
European Journal of Haematology|August 30, 2024
Idiopathic multicentric Castleman disease with marrow fibrosis and extramedullary hematopoiesisMarley Blommers, Sorin Selegean, Richard K Wood, et al.
Pageof 2